Personalized daily step targets to change body fat and cardiometabolic risk in adults with overweight or obesity
Official title: Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults
Run by Kennesaw State University · NCT07221279 · Data updated 2026-11-12
This project will test if giving personalized daily step targets based on body fat helps adults with overweight or obesity change body composition and lower cardiometabolic risk.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Kennesaw State University Academic / other |
| Locations | 1 site (Kennesaw, Georgia) |
| Status | Recruiting |
| Started | January 13, 2025 |
| Main results expected | August 31, 2027 |
| Study ends | August 31, 2027 |
| Registry record updated | October 27, 2025 |
| Trial ID | NCT07221279 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are otherwise-healthy adults age 20 or older with overweight or obesity who are sedentary or only walk (no recent structured exercise) and have had stable weight over the past six months.
✕Probably not a fit
People with diagnosed cardiovascular, metabolic, renal, or pulmonary disease, cognitive dysfunction, current smokers, pregnant people, those taking glucose-regulating or metabolism-altering medications, or those with recent substantial weight change are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will measure body composition and key cardiometabolic risk markers while participants wear inexpensive triaxial pedometers for four weeks to record daily steps. Step counts will be expressed as steps per kilogram of fat mass per day and related to body composition and cardiometabolic profiles across four age groups (20-39, 40-59, 60-79, and 80+ years). The goal is to build a model that prescribes step targets that predictably change body weight and cardiometabolic risk while participants eat ad libitum. Participants will be generally healthy overweight or obese adults who are sedentary or who walk but have not done structured exercise recently.
Why it matters
Potential benefit: If successful, this approach could offer a simple, low-cost way to set walking targets that produce predictable improvements in body composition and cardiometabolic health.
How similar studies have gone: Pilot data and prior step-count research show links between walking and body fat/CMR, but prescribing steps normalized to fat mass for predictable weight and risk changes is a novel, less-tested approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ages of 20 years and older * otherwise healthy adults on prescription medication to treat hypertension or osteoarthritic conditions are eligible to participate * sedentary people, or people who report engaging in regular walking (no regular structured exercise for at least the past six months) * relatively stable weight over the previous 6 months (less than 5% fluctuation in body weight) Exclusion Criteria: * any diagnosed cardiovascular, metabolic, renal, or pulmonary disease, or any diagnosed cognitive dysfunction * women who are pregnant or plan on becoming pregnant * people taking prescription medication to regulate plasma glucose, or that affect metabolism (e.g., thyroid medication) * people who have undergone an increase or decrease in body weight of ≥ 5% over the previous six months * current smokers * people who have engaged in a program of structured exercise other than walking (e.g., weight training, jogging, swimming, cycling) within that last six months * older adults (60-plus years old) who score \> 4 on the Short Blessed Test for geriatric cognitive impairment during the first lab visit will be ineligible to participate
Where it's running
-
Kennesaw State Universityh
Kennesaw, Georgia, United States Recruiting
Study contacts
- Principal investigator: Robert Buresh, PhD — Kennesaw State University
- Study coordinator: Robert Buresh, PhD
- Email: rburesh@kennesaw.edu
- Phone: 470-578-6488
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Kodo Millet Porridge and Gut Health in Overweight and Obese Adults
This study tests whether daily intake of Kodo millet porridge for 12 weeks can improve gut bacteria and metabolic health in adults who are overweight or obese.
-
Taiwan green propolis for MASLD and lipid/metabolic issues
This study tests whether Taiwan green propolis capsules can improve blood lipids and body fat in adults with MASLD compared to a placebo over 12 weeks.
-
Two-drug interaction study of UIC202601 and UIC202602 in healthy adults
This study tests whether combining two investigational drugs changes how they behave in the body and whether the combination is safe in healthy volunteers.
-
Polypill Approach for Multiple Cardiovascular Risk Factors
Researchers are testing a fixed-dose pill strategy to help people aged 50–75 with high blood pressure, high cholesterol, and diabetes see if it lowers their heart-disease risk and reduces future events.
-
Goal-commitment coaching to boost proactive health actions in adults with hypertension, diabetes, or high cholesterol
This project will try a goal-commitment behavioral program to see if it helps adults with hypertension, diabetes, or high cholesterol adopt more proactive health habits.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.